Setra 50 Tablet
by GENERAL Pharmaceuticals Ltd.
৳7.00
Silva Pharmaceuticals Limited
Sertraline Hydrochloride
Major Depressive Disorder, Obsessive Compulsive Disorder (OCD), Panic Disorder, Posttraumatic Stress Disorder (PTSD), Premenstrual Dysphoric Disorder (PMDD), Social Anxiety Disorder
Sertraline has potent and selective inhibitory action on CNS neuronal reuptake of 5-HT resulting in increased 5-HT concentrations at the synaptic clefts, leading to facilitation of its sustained activity at the postsynaptic receptor sites. It ultimately results in an improvement of depression. Reduction of Serotonin turnover in brain by Sertraline is also another contributing fact implicated in its action. Its prolonged elimination half-life offers a benefit of once daily administration.
Adults-
Major depressive disorder:
Obsessive-compulsive disorder:
Panic disorder, Post-traumatic stress disorder, Social anxiety disorder:
Pediatric Patients (ages 6-12 years old)-
Obsessive-compulsive disorder:
The recommended interval between dose changes is one week.
Premenstrual dysphoric disorder (PMDD): Starting dosage for PMDD is 50 mg/day. Sertraline may be administered either continuously (every day throughout the menstrual cycle) or intermittently (starting the daily dosage 14 days prior to the anticipated onset of menstruation and continuing through the onset of menses). Intermittent dosing would be repeated with each new cycle.
Sertraline is closely linked to plasma protein, so giving it to a patient who is also taking another medicine that is tightly bound to protein (e.g. warfarin, digitoxin) could produce a shift in plasma concentrations, potentially causing an undesirable impact. Displacement of protein-bound Sertraline by other firmly bound medicines, on the other hand, may have negative consequences. Sertraline may interact with other medications including Cimetidine, CNS active pharmaceuticals like Diazepam, Hypoglycemic meds, and Atenolol, among others.
Sertraline is not recommended for patients who have a known hypersensitivity to the medicine or any of its excipients. It is not indicated for persons with moderate to severe hepatic impairment.
Sertraline can cause stomach upset, diarrhoea, constipation, vomiting, dry mouth, loss of appetite, weight gain, sleepiness, dizziness, headache, pain, burning or tingling in the hands or feet, excitation, and a sore throat, among other things.
Sertraline's safety during human pregnancy has not been demonstrated, despite the fact that no indication of teratogenicity has been found in animal research. Sertraline has been found to pass through breast milk. Its impact on nursing infants has yet to be determined. If Sertraline medication is required, it may be essential to stop breastfeeding.
If you have liver disease, kidney disease, seizures, heart disease, or allergies, you should use caution. This medication may cause drowsiness or dizziness. Activities that necessitate alertness, such as driving or operating machinery, should be approached with caution. When taking this medicine in the elderly, use caution because they may be more susceptible to the drug's effects. If you've used a monoamine oxidase inhibitor in the recent five weeks, don't take this medication. Suicidal ideation and behavioural changes are a possibility (close monitoring of the patient after 2 to 3 weeks of use is required).
SSRIs & related anti-depressant drugs
Do not store above 30°C. Keep out of the reach of children.
Silva Pharmaceuticals Ltd.
by Renata Pharma Ltd
৳6.00